Survey of naturally occurring CD4(+) T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

NY-ESO-1 is one of the most immunogenic proteins described in human cancers, based on its capacity to elicit simultaneous antibody and CD8(+) T cell responses in vivo. Although HLA class II restricted epitopes from NY-ESO-1 have been identified, no broad survey has yet established the status of natu...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Gnjatic, Sacha, Atanackovic, Djordje, Jäger, Elke, Matsuo, Mitsutoshi, Selvakumar, Annamalai, Altorki, Nasser K., Maki, Robert G., Dupont, Bo, Ritter, Gerd, Chen, Yao-Tseng, Knuth, Alexander, Old, Lloyd J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 2003
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166404/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12853579/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.1133324100
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!